Over the Counter Drugs Market

Page 1

The market is expected to register a growth rate of 5.8% over forecast period. The worldwide Over-the-Counter (OTC) Drugs Market was valued over US$ 120 Bn in the year 2018. The introduction on new products into market and expanding geriatric population base is expected to accelerate the adoption of Over-the-Counter (OTC) Drugs and hence drive the market growth. The preference for (OTC) Drugs from pharmaceutical industry is increasing significantly and this is observed due to demand from consumers for carrying out self-medication. The shift of pharmaceutical industries to Over-the-Counter (OTC) Drugs is expected to be one of the major industry trends. For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

The developing countries are expected to be quick adopter of Over-the-Counter (OTC) drugs as the consumers in this region are more focused on cost reduction by saving the consultation cost required to pay. Request a Sample Copy of Over the Counter Drugs Market@ https://www.acumenresearchandconsulting.com/request-sample/1171 The inclination towards the traditional medication methods in few of the underdeveloped economies is expected to be one of the restraining factor for the growth of market. Also, other factors such as substance abuse and incorrect diagnosis are some of the major factors limiting the growth of Over-the-Counter (OTC) drugs market. Also, due to some chemical composition failures or allergic reactions of Over-the-Counter (OTC) drugs have made call back of drugs from stores several times in past years this significantly affects the market in a negative way. The global Over-the-Counter (OTC) Drugs market is segmented into product, and region. On the basis product, the global Over-the-Counter (OTC) Drugs market is segmented into Analgesics, Cold, Cough & Flu Products, Weight Loss Products, Gastrointestinal Products, Skin Products, Mineral and Vitamin Supplements, Sleeping Aids, Ophthalmic Products. On the basis of region the global agricultural fumigants market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific. In terms of demand the Over-the-Counter (OTC) Drugs in the type of minerals, vitamins and supplement are dominating the global market in 2018. This segment is holding major market share of over 25%. The demand for minerals, vitamins and supplement is very high in the developed economies including U.S., Japan, and others. In addition to this, increasing healthcare issues to due changing eating habits is fuelling the demand for minerals, vitamins and supplement as the Over-the-Counter (OTC) Drugs in developing regions as well. Such factors are increasing demand for Over-the-Counter (OTC) Drugs and hence boosting the market growth. For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

Browse Full Report with Table of Content, List of Table and Figures@ https://www.acumenresearchandconsulting.com/over-the-counter-otcdrugs-market The rise in allergic reactions, frequent aching, and other diet deficiency problems due to changing eating habits and busy lifestyles is boosting the adoption of Over-the-Counter (OTC) drugs at global level. The developed region are becoming increasingly focused on controlling the usage of Over-the-Counter (OTC) drugs to promote the physicians consultations and promote the importance of clinical visits which is limiting the growth of Over-the-Counter (OTC) drugs market in this region. Considering such factors, the North America region is expected to register moderate growth rate. On the other hand, the developing region such as APAC region is expected to witness significant increase in terms of demand for Over-the-Counter (OTC) drugs and China market is holding a significant market share with over 15% of global over-the-counter drugs market share. The strong presence of Over-the-Counter (OTC) drugs manufacturers and increasing production of pharmaceuticals in this region is boosting the demand for drugs. Currently, the Over-the-Counter (OTC) drugs market is significantly dominated by some of the potential economies including U.S., Japan, and China. The major economies are foreseen to capture significant market share in the Over-theCounter (OTC) drugs market in 2018. Considering the demand from consumers for Over-the-Counter (OTC) drugs, the U.S and Japan are expected to register moderate growth rate over forecast period due to saturation in terms of demand and strong regulatory parameters present in these countries. The Over-the-Counter (OTC) drugs manufacturers are increasing focusing delivering products as per regulations and standards enforced by governments and different organizations and associations. Some of the key players present in the Over-the-Counter (OTC) drugs market are companies including Dr. Reddy’s Laboratories, Sanofi, Merck KGaA, Sun Pharmaceutical Industries Ltd., Pfizer,

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

Takeda, Johnson & Johnson, Alkem Laboratories Limited, GloxoSmithKline,Bayer, Cipla, Glenmark Pharmaceuticals Limited, and others. Browse More Press Release, Click Here: https://www.acumenresearchandconsulting.com/press-releases TABLE OF CONTENT CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Over-the-Counter (OTC) Drugs 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Over-the-Counter (OTC) Drugs Market By Product 1.2.2.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate Comparison By Product (2015-2026) 1.2.2.2. Global Over-the-Counter (OTC) Drugs Market Revenue Share By Product in 2017 1.2.2.3. Analgesics 1.2.2.4. Cold 1.2.2.5. Cough & Flu Products 1.2.2.6. Weight Loss Products 1.2.2.7. Gastrointestinal Products 1.2.2.8. Skin Products 1.2.2.9. Mineral and Vitamin Supplements 1.2.2.10. Sleeping Aids 1.2.2.11. Ophthalmic Products 1.2.2.12. Others 1.2.3. Over-the-Counter (OTC) Drugs Market by Geography 1.2.3.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

Comparison by Geography (2015-2026) 1.2.3.2. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026) 1.2.3.3. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026) 1.2.3.4. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026) 1.2.3.5. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026) 1.2.3.6. Middle East and Africa (MEA) Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026) CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017 CHAPTER 4. OVER-THE-COUNTER (OTC) DRUGS MARKET BY PRODUCT 4.1. Global Over-the-Counter (OTC) Drugs Revenue By Product 4.2. Analgesics 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.3. Cold 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.4. Cough & Flu Products 4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.5. Weight Loss Products 4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.6. Gastrointestinal Products 4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.7. Skin Products 4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.8. Mineral and Vitamin Supplements For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.9. Sleeping Aids 4.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.10. Ophthalmic Products 4.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.11. Others 4.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 5. NORTH AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 5.1. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.2. North America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 5.3. U.S. 5.3.1. U.S. Over-the-Counter (OTC) Drugs Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 5.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 5.4. Canada 5.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 5.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 5.5. Mexico 5.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 5.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

CHAPTER 6. EUROPE OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 6.1. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.2. Europe Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 6.3. UK 6.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 6.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 6.4. Germany 6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 6.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 6.5. France 6.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 6.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 6.6. Spain 6.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 6.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 6.7. Rest of Europe 6.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 6.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 7. ASIA-PACIFIC OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 7.1. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.2. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 7.3. China 7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.4. Japan For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.5. India 7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.6. Australia 7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.7. South Korea 7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 7.8. Rest of Asia-Pacific 7.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 7.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 8. LATIN AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 8.1. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 8.2. Latin America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 8.3. Brazil 8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.4. Argentina 8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 8.5. Rest of Latin America 8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

CHAPTER 9. MIDDLE EAST OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 9.1. Middle East Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 9.2. Middle East Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 9.3. Saudi Arabia 9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.4. UAE 9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 9.5. Rest of Middle East 9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) CHAPTER 10. AFRICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY 10.1. Africa Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million) 10.2. Africa Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%) 10.3. South Africa 10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.4. Egypt 10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million) 10.5. Rest of Africa 10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million) 10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

CHAPTER 11. COMPANY PROFILE 11.1. Johnson & Johnson 11.1.1. Company Snapshot 11.1.2. Overview 11.1.3. Financial Overview 11.1.4. Product Portfolio 11.1.5. Key Developments 11.1.6. Strategies 11.2. Cipla 11.2.1. Company Snapshot 11.2.2. Overview 11.2.3. Financial Overview 11.2.4. Product Portfolio 11.2.5. Key Developments 11.2.6. Strategies 11.3. Sun Pharmaceutical Industries Ltd. 11.3.1. Company Snapshot 11.3.2. Overview 11.3.3. Financial Overview 11.3.4. Product Portfolio 11.3.5. Key Developments 11.3.6. Strategies 11.4. Dr. Reddy’s Laboratories 11.4.1. Company Snapshot 11.4.2. Overview 11.4.3. Financial Overview 11.4.4. Product Portfolio 11.4.5. Key Developments 11.4.6. Strategies 11.5. Merck KGaA 11.5.1. Company Snapshot For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

11.5.2. Overview 11.5.3. Financial Overview 11.5.4. Product Portfolio 11.5.5. Key Developments 11.5.6. Strategies 11.6. Bayer 11.6.1. Company Snapshot 11.6.2. Overview 11.6.3. Financial Overview 11.6.4. Product Portfolio 11.6.5. Key Developments 11.6.6. Strategies 11.7. Pfizer 11.7.1. Company Snapshot 11.7.2. Overview 11.7.3. Financial Overview 11.7.4. Product Portfolio 11.7.5. Key Developments 11.7.6. Strategies 11.8. Alkem Laboratories Limited 11.8.1. Company Snapshot 11.8.2. Overview 11.8.3. Financial Overview 11.8.4. Product Portfolio 11.8.5. Key Developments 11.8.6. Strategies 11.9. GloxoSmithKline 11.9.1. Company Snapshot 11.9.2. Overview 11.9.3. Financial Overview 11.9.4. Product Portfolio 11.9.5. Key Developments For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

11.9.6. Strategies 11.10. Sanofi 11.10.1. Company Snapshot 11.10.2. Overview 11.10.3. Financial Overview 11.10.4. Product Portfolio 11.10.5. Key Developments 11.10.6. Strategies 11.11. Takeda 11.11.1. Company Snapshot 11.11.2. Overview 11.11.3. Financial Overview 11.11.4. Product Portfolio 11.11.5. Key Developments 11.11.6. Strategies 11.12. Glenmark Pharmaceuticals Limited 11.12.1. Company Snapshot 11.12.2. Overview 11.12.3. Financial Overview 11.12.4. Product Portfolio 11.12.5. Key Developments 11.12.6. Strategies 11.13. Others 11.13.1. Company Snapshot 11.13.2. Overview 11.13.3. Financial Overview 11.13.4. Product Portfolio 11.13.5. Key Developments 11.13.6. Strategies

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

CHAPTER 12. RESEARCH APPROACH 12.1. Research Methodology 12.1.1. Initial Data Search 12.1.2. Secondary Research 12.1.3. Primary Research 12.2. Assumptions and Scope To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1171

The report is readily available and can be dispatched immediately after payment confirmation. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

For Report Sample Contact: sales@acumenresearchandconsulting.com | +1 407 915 4157

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.